Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Arizona Retailer Rejects Products Tested By Two Cannabis Labs
Story Cannabis will stop accepting products tested by two Arizona cannabis laboratories after regulatory findings involving testing accuracy and potency. The decision shows how laboratory quality can affect retail access, inventory, supplier trust, product liability, and consumer confidence even beyond minimum state testing requirements.
Ohio Dispensary Closure Raises Cannabis Vape Safety Questions
An Ohio dispensary voluntarily closed after two customers reported serious adverse health effects involving cannabis vapes. Follow up testing found no harmful contaminants, but the investigation shows how quickly product complaints can trigger inventory holds, operational disruption, recall procedures, and claims exposure.
Missouri Recalls Cannabis Products Over Modified Cannabinoids
Missouri regulators recalled cannabis products from GF Extraction Lab LLC after finding cannabinoids produced through chemical modification, conversion, or synthetic derivation. The action highlights growing pressure around manufacturing controls, ingredient traceability, testing, inventory management, recalls, and retailer compliance.
Michigan Suspends Hemp License Over Excessive THC
Michigan regulators suspended a hemp processor handler license after an investigation identified products with reported delta 9 THC concentrations far above the state's 0.3 percent hemp limit. The case shows why COAs, inventory audits, product classification, and supplier documentation are becoming critical licensing controls.
Oklahoma Cannabis Testing Problems Keep Pressure On Market Integrity
Oklahoma’s cannabis market continues to face THC potency inflation, lab shopping, unsafe product concerns, and delays tied to the state’s reference lab. The bigger lesson is that weak lab oversight can distort product value, create recall exposure, reward bad operators, and punish compliant businesses.
Massachusetts THC Potency Audits Turn Label Accuracy Into A Shelf Risk
Massachusetts regulators are beginning THC potency audits for retail cannabis products, and products testing outside the allowed range may be removed from shelves. The bigger lesson is that potency claims are now a real compliance and enforcement issue for operators across the supply chain.
Colorado Crackdown on Hemp THC Inversion Raises Supply Chain Risk
Colorado regulators are escalating their response to hemp THC inversion with emergency rules, tougher testing, and supply chain scrutiny. The bigger operator lesson is simple: if your sourcing and transfer records are messy, the crackdown is bigger than a lab issue.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.